Stockreport

Anavex Life Sciences Highlights Oral Alzheimer's Drug Blarcamesine, Precision Strategy at JPM Conference [Yahoo! Finance]

Anavex Life Sciences Corp.  (AVXL) 
NASDAQ:AMEX Investor Relations: anavex.com/share-data
PDF weeks (up to 49.8% in a pre-specified population) with a “very solid” safety profile and biomarker signals including reduced brain atrophy and effects on Aß42 plasma rat [Read more]